Physician profile
Nathan Han
NPI 1417484569
$9,975.84
in general payments reported to CMS, 2019-2025
10 companies · $4,458 in 2025
The $4,458 reported for 2025 was more than what 79% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $5,518 · 2025: $4,458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,427 · Food and Beverage: $4,248 · Education: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,426.50 |
| Food and Beverage | $4,247.95 |
| Education | $301.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,437.68 | 2024-2025 | Cd Horizon Spinal System, Unid_pass, Mazor X System |
| Alphatec Spine, INC | $2,777.71 | 2024-2025 | Other - Miscellaneous, Invictus Mis, Lif |
| Globus Medical, INC. | $2,258.70 | 2024-2025 | Xlif, Captivate, Tlif |
| Stryker Corporation | $397.90 | 2024-2025 | Na |
| Carlsmed, INC. | $376.97 | 2025 | Aprevo |
| Spineart USA INC | $280.94 | 2025 | Scarlet Al-T |
| Si-Bone, INC. | $259.19 | 2024-2025 | |
| Depuy Synthes Sales INC. | $97.78 | 2024 | Teligen |
| Pacira Pharmaceuticals Incorporated | $68.78 | 2024-2025 | Exparel |
| Centinel Spine, LLC | $20.19 | 2025 | Prodisc C Vivo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.